Figure 6: (A) Immunoblots showing the expression of HO-1 protein level from ischemic brain tissue of simvastatin (20 mg·kg-1 daily for 14 days, closed bars) or atorvastatin (10 mg·kg-1 daily for 14 days, open bars) with or without L-NAME (15 mg·kg-1 daily for 14 days)-treated groups after 3 h and 12 h of pMCAO. (B) [NO]/[ONOO- ] from ischemic brain tissue of simvastatin (closed bars) or atorvastatin (open bars) with or without L-NAME-treated groups after 3 h and 12 h of pMCAO. All values are mean ± SEM of n=6. *P< 0.05 vs. 3 h of pMCAO of either simvastatin- or atorvastatin-treated group.